AMIT KUMAR SRIVASTAVA

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Tumor-associated macrophages contribute to cisplatin resistance via regulating Pol η-mediated translesion DNA synthesis in ovarian cancer
  Cellular and Molecular Life Sciences 2025 DOI: 10.1007/s00018-025-05731-8
  +Save
• Ellagic Acid Induces DNA Damage and Apoptosis in Cancer Stem-like Cells and Overcomes Cisplatin Resistance
  ACS Omega 2024 DOI: 10.1021/acsomega.3c08819
  +Save
• Isolation, Characterization, In Vitro and In Silico Assessment of Undescribed Bioactive Constituents from Pterocarpus santalinus L. Heartwood
  ACS Omega 2024 DOI: 10.1021/acsomega.3c10180
  +Save
• The EXO1/Polη/Polι axis as a promising target for miR-3163-mediated attenuation of cancer stem-like cells in non-small cell lung carcinoma
  British Journal of Cancer 2024 DOI: 10.1038/s41416-024-02840-2
  +Save
• Neil 1 deficiency facilitates chemoresistance through upregulation of RAD18 expression in ovarian cancer stem cells
  Biochemical and Biophysical Research Communications 2024 DOI: 10.1016/j.bbrc.2024.149907
  +Save
• Interleukin‐1β activated c‐FOS transcription factor binds preferentially to a specific allele of the matrix metalloproteinase‐13 promoter and increases susceptibility to endometriosis
  Journal of Cellular Physiology 2022 DOI: 10.1002/jcp.30773
  +Save
• KLF8 is activated by TGF‐β1 via Smad2 and contributes to ovarian cancer progression
  Journal of Cellular Biochemistry 2022 DOI: 10.1002/jcb.30235
  +Save
• DNA polymerase eta: A potential pharmacological target for cancer therapy
  Journal of Cellular Physiology 2021 DOI: 10.1002/jcp.30155
  +Save